197 related articles for article (PubMed ID: 31705457)
21. Application of comprehensive pharmaceutical care program in identifying and addressing drug-related problems in hospitalized patients with osteoporosis.
Chen W; Zhang H; Jiang J; Zhang X; Ding J; Liu Y; Dang H
BMC Health Serv Res; 2022 Nov; 22(1):1438. PubMed ID: 36443812
[TBL] [Abstract][Full Text] [Related]
22. Effect of clinical pharmacist intervention on the treatment of acute pancreatitis.
Niu JL; Ding YL; Ju F; Lu T; Xue T; Chen KX; Chen HJ; Zhao GY
Int J Clin Pharm; 2019 Dec; 41(6):1652-1657. PubMed ID: 31696422
[TBL] [Abstract][Full Text] [Related]
23. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
[TBL] [Abstract][Full Text] [Related]
24. Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina.
Ljubojević G; Miljković B; Bućma T; Ćulafić M; Prostran M; Vezmar Kovačević S
Int J Clin Pharm; 2017 Aug; 39(4):743-749. PubMed ID: 28597173
[TBL] [Abstract][Full Text] [Related]
25. Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.
Rodrigues JPV; Marques FA; Gonçalves AMRF; Campos MSA; Reis TMD; Morelo MRS; Fontoura A; Girolineto BMP; Souza HPMC; Cazarim MS; Maduro LCDS; Pereira LRL
PLoS One; 2019; 14(1):e0210779. PubMed ID: 30657771
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.
Ali MAS; Khedr EMH; Ahmed FAH; Mohamed NNE
Int J Clin Pharm; 2018 Oct; 40(5):1257-1264. PubMed ID: 29922968
[TBL] [Abstract][Full Text] [Related]
27. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
28. Cross-sectional investigation of drug-related problems among adults in a medical center outpatient clinic: application of virtual medicine records in the cloud.
Wang HY; Yeh MK; Ho CH; Hu MK; Huang YB
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):71-80. PubMed ID: 27730699
[TBL] [Abstract][Full Text] [Related]
29. Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
Eichenberger PM; Lampert ML; Kahmann IV; van Mil JW; Hersberger KE
Pharm World Sci; 2010 Jun; 32(3):362-72. PubMed ID: 20229029
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of drug-related problems and pharmacists' interventions in a geriatric unit in China.
Ma Z; Sun S; Zhang C; Yuan X; Chen Q; Wu J; Wang X; Liu L
Int J Clin Pharm; 2021 Feb; 43(1):270-274. PubMed ID: 32860599
[TBL] [Abstract][Full Text] [Related]
31. Impact of medication therapy management on pharmacotherapy safety in an intensive care unit.
Martins RR; Silva LT; Lopes FM
Int J Clin Pharm; 2019 Feb; 41(1):179-188. PubMed ID: 30552623
[TBL] [Abstract][Full Text] [Related]
32. Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort.
Saldanha V; Randall Martins R; Lima SIVC; Batista de Araujo I; Gouveia Oliveira A
BMJ Open; 2020 Apr; 10(4):e035848. PubMed ID: 32332007
[TBL] [Abstract][Full Text] [Related]
33. DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE.
Nascimento ARFD; Leopoldino RWD; Santos METD; Costa TXD; Martins RR
Rev Paul Pediatr; 2020; 38():e2018134. PubMed ID: 31939506
[TBL] [Abstract][Full Text] [Related]
34. Assessment of drug-related problems in pediatric ward of Zewditu Memorial Referral Hospital, Addis Ababa, Ethiopia.
Birarra MK; Heye TB; Shibeshi W
Int J Clin Pharm; 2017 Oct; 39(5):1039-1046. PubMed ID: 28689305
[TBL] [Abstract][Full Text] [Related]
35. Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients.
Ottenbros S; Teichert M; de Groot R; Griens F; Sodihardjo F; Wensing M; de Gier JJ
Int J Clin Pharm; 2014 Apr; 36(2):336-44. PubMed ID: 24293335
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a method for drug-related problems identification and classification in hospital setting: applicability and reliability.
Modesto ACF; Ribeiro AM; Pereira JL; Silva LT; Provin MP; Ferreira PSLAI; Amaral RG; Ferreira TXAM
Int J Clin Pharm; 2020 Feb; 42(1):193-200. PubMed ID: 31865595
[TBL] [Abstract][Full Text] [Related]
37. The process of identifying, solving and preventing drug related problems in the LIMM-study.
Bergkvist Christensen A; Holmbjer L; Midlöv P; Höglund P; Larsson L; Bondesson Å; Eriksson T
Int J Clin Pharm; 2011 Dec; 33(6):1010-8. PubMed ID: 22081243
[TBL] [Abstract][Full Text] [Related]
38. Drug related problems in the neonatal intensive care unit: incidence, characterization and clinical relevance.
Leopoldino RD; Santos MT; Costa TX; Martins RR; Oliveira AG
BMC Pediatr; 2019 Apr; 19(1):134. PubMed ID: 31027487
[TBL] [Abstract][Full Text] [Related]
39. Pharmacists' performance of clinical interventions during adherence support medication reviews.
Hatah E; Tordoff J; Duffull SB; Braund R
Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
[TBL] [Abstract][Full Text] [Related]
40. The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals.
Meijvis VAM; Heringa M; Kwint HF; de Wit NJ; Bouvy ML
Res Social Adm Pharm; 2023 Jul; 19(7):1054-1060. PubMed ID: 37095031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
